Concepedia

Nieves Martínez Chanzá

NM

15

Publications

686

Citations

13

H-Index

2018

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Institut Jules Bordet

Brigham and Women's Hospital

Huntsman Cancer Institute

Emory University

Nieves Martínez Chanzá is an author at Dana-Farber Cancer Institute specializing in oncology, cancer research, and urology.

ORCID

Top concepts

Publications per year

2018–2023

15

Publications

15

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 173 citations

, , +8

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma

Amin H. Nassar, Sarah Abou Alaiwi, Saud H. AlDubayan et al. · Genetics in Medicine · 2019 · 110 citations · Full text

Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma

Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah et al. · JAMA Oncology · 2021 · 93 citations · Full text

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma

Sarah Abou Alaiwi, Wanling Xie, Amin H. Nassar et al. · Journal for ImmunoTherapy of Cancer · 2020 · 82 citations · Full text

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas

Jonathan Thouvenin, Omar Alhalabi, Maria I. Carlo et al. · The Oncologist · 2022 · 35 citations · Full text

Rows per page

1–5 of 15